For Immediate Release |
|
("Sopheon" or the "Company")
DIRECTOR SHAREHOLDING
Sopheon plc, the international provider of software and services that improve the financial return from innovation and product development investments, announces that it was informed today that certain directors purchased shares, following the share consolidation processed on 14 October. Under the consolidation, every 500 existing ordinary shares of 20 pence each were consolidated into one new ordinary share of £100 each ("New Ordinary Shares").
Holdings listed below reflect New Ordinary Shares held by the director concerned and all his related parties.
|
Existing Holding |
Number Acquired |
Updated Holding |
Barry Mence |
2,033 |
33 |
2,066 |
Stuart Silcock |
286 |
11 |
297 |
Bernard Al |
120 |
3 |
123 |
Andrew Michuda |
58 |
2 |
60 |
Arif Karimjee |
34 |
1 |
35 |
All shares were purchased on 27 October 2014 at a price per share of €233.76.
For further information contact:
Barry Mence, Chairman |
Sopheon plc |
+ 44 (0) 1483 685 735 |
Arif Karimjee, CFO |
Sopheon plc |
+ 44 (0) 1483 685 735 |
Charlotte Stranner / Victoria Bates |
finnCap |
+ 44 (0) 20 7600 1658 |
Heather Armstrong |
Newgate Threadneedle |
+ 44 (0) 20 7653 9842 |
Claire Verhagen |
Citigate First Financial |
+ 31 (0) 205 754 010 |
About Sopheon
Sopheon (LSE: SPE) partners with customers to provide complete Enterprise Innovation Performance solutions including software, expertise, and best-practices to achieve exceptional long-term revenue growth and profitability. Sopheon's Accolade® solution provides unique, fully-integrated coverage for the entire innovation management and new product development lifecycle. For the first time, businesses can access a single source of the truth across strategic innovation planning, roadmapping, idea and concept development, process and project management, and portfolio and in-market management. Sopheon's solutions have been implemented by over 200 customers with over 60,000 users in over 50 countries. Sopheon is listed on the AIM Market of the London Stock Exchange and on the Alternext Exchange in the Netherlands. For more information, please visit www.sopheon.com